Shattuck Labs drops after announcing equity offering

Shattuck Labs

09/06/2026 21:54

** Biotech firm Shattuck Labs' STTK.O shares down 4.2% to $4.09 in extended trading after equity offering news
** Inflammatory and immune-mediated diseases-focused firm commences offering of stock and pre-funded warrants; deal size not disclosed
** Leerink Partners, J.P. Morgan, Piper Sandler and Cantor Fitzgerald joint bookrunners
** STTK shares rose 9.5% to close at $4.27 on Tues, up 17% YTD
** Austin, Texas-based co has ~76.7 mln shares outstanding for roughly $330 mln market cap
** All 8 analysts are bullish on the stock, including 2 "strong buy" ratings; median PT $17, according to LSEG data

(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@tr.com 1-646-279-6380))